Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2026

Percentage of Net Product Sales and Accounts Receivable Balance

The following table includes the percentage of net product sales and accounts receivable balances for our three major Customers, each of which comprised 10% or more of our product sales:


	Net Product Sales						Accounts Receivable
	Three Months Ended June 30, 2026			Six Months Ended June 30, 2026			As of June 30, 2026
Customer A		41.1	%		38.8	%		40.1	%
Customer B		30.6	%		33.4	%		34.3	%
Customer C		26.1	%		25.7	%		24.8	%
Total		97.8	%		97.9	%		99.2	%

Schedule of Disaggregated Net Product Sales

The following table provides disaggregated net product sales (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
CINVANTI net product sales	$	21,793	$	24,143	$	42,328	$	49,886
SUSTOL net product sales		540		2,404		1,088		5,263
ZYNRELEF net product sales		11,056		8,189		21,291		16,230
APONVIE net product sales		4,277		2,464		7,670		4,724
Total net product sales	$	37,666	$	37,200	$	72,377	$	76,103

Summary of Activity to Product Returns, Distributor Fees and Discounts, Rebates and Administrative Fees

The following table provides a summary of activity with respect to our product returns, distributor fees and discounts, rebates and administrative fees, which are included in other accrued liabilities on the condensed consolidated balance sheets (in thousands):


	Product Returns			Distributor Fees			Discounts, Rebates and Administrative Fees			Total
Balance at December 31, 2025	$	4,515		$	7,328		$	34,152		$	45,995
Provision		334			17,307			111,454			129,095
Payments/credits		(636	)		(16,506	)		(110,083	)		(127,225	)
Balance at June 30, 2026	$	4,213		$	8,129		$	35,523		$	47,865

Schedule of Numerator (Earnings or Loss) and Denominator (Shares) to Calculate the Basic and Diluted Earnings Per Share

the computations of the numerator (earnings or loss) and denominator (shares) to calculate the basic and diluted earnings per share amounts presented in the accompanying condensed consolidated statements of operations and comprehensive (loss) income are as follows (in thousands, except per share amounts):


	Six Months Ended June 30, 2025
	Income		Shares
Basic:
Net income	$	254		153,804

Earnings per share, basic	$	0.00

Diluted:
Net income	$	254		153,804
Effect of dilutive securities:
Stock options outstanding		—		29,697
Restricted stock units outstanding		—		4,133
Warrants outstanding		—		298
Shares of common stock underlying convertible notes outstanding		—		9,819
Net income, diluted	$	254		197,751

Earnings per share, diluted	$	0.00

Common Stock Equivalents Excluded From Computation of Net Loss Per Share

Because we have incurred a net loss for the three and six months ended June 30, 2026 and the three months ended June 30, 2025, the following common stock equivalents were not included in the computation of net loss per share because their effect would be anti-dilutive (in thousands):


	As of June 30,
	2026		2025
Stock options outstanding		28,263		29,697
Restricted stock units outstanding		10,579		4,133
Warrants outstanding		298		298
Series A Preferred Stock convertible to common shares		700		—
Shares of common stock underlying convertible notes outstanding		19,444		9,819

For the six months ended June 30, 2025, we recognized net income. Accordingly, the computations of the numerator (earnings or loss) and denominator (shares) to calculate the basic and diluted earnings per share amounts presented in the accompanying condensed consolidated statements of operations and comprehensive (loss) income are as follows (in thousands, except per share amounts):


	Six Months Ended June 30, 2025
	Income		Shares
Basic:
Net income	$	254		153,804

Earnings per share, basic	$	0.00

Diluted:
Net income	$	254		153,804
Effect of dilutive securities:
Stock options outstanding		—		29,697
Restricted stock units outstanding		—		4,133
Warrants outstanding		—		298
Shares of common stock underlying convertible notes outstanding		—		9,819
Net income, diluted	$	254		197,751

Earnings per share, diluted	$	0.00